Table of Content

  1. INTRODUCTION
    1. Study Assumptions and Market Definition
    2. Scope of the Study
  2. RESEARCH METHODOLOGY
  3. EXECUTIVE SUMMARY
  4. MARKET DYNAMICS
    1. Market Overview
    2. Market Drivers
      1. Surge in Chronic Illnesses such as Obesity and Diabetes
    3. Market Restraints
      1. Challenges in Standardization of Treatment Protocols
      2. Risk of Bleeding with Anticoagulant Therapies
    4. Market Opportunities
      1. Advancements in Technology
    5. Market Trends
      1. Rise of Hybrid Ablation Procedures
      2. Growing Focus on Artificial Intelligence (AI) and Machine Learning
  5. MARKET SEGMENTATION
    1. By Treatment Type
      1. Pharmacological Treatment
        1. Anti-arrhythmic Drugs
        2. Anticoagulant Drugs
      2. Non-Pharmacological Treatment
        1. Catheter Ablation
          1. Radiofrequency
          2. HIFU
          3. Cryoablation
          4. Microwave
          5. Laser
        2. Maze Surgery
        3. Electric Cardioversion
    2. By Key Geographic Regions
      1. North America
        1. United States
        2. Canada
        3. Mexico
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
      3. Asia Pacific
        1. China
        2. Japan
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia Pacific
      4. Middle East and Africa
        1. GCC
        2. South Africa
        3. Rest of Middle East and Africa
      5. South America
        1. Brazil
        2. Argentina
        3. Rest of South America
  6. COMPETITIVE LANDSCAPE
    1. Company Profile
      1. AtriCure Inc.
      2. Abbott (St. Jude Medical Inc.)
      3. Boehringer Ingelheim GmbH
      4. Boston Scientific Corporation
      5. Bristol- Myers Squibb Corporation
      6. Biosense Webster Inc.
      7. Cardio Focus Inc.
      8. Endoscopic Technologies Inc.
      9. Johnsons & Johnson
      10. Sanofi Aventis

7. MARKET OPPORTUNITIES AND FUTURE TRENDS



Frequently Asked Questions

Q.1. What is the projected market value of the global Atrial Fibrillationmarket?

The global market of Atrial Fibrillation is projected to reach USD 19.3 Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global Atrial Fibrillationmarket?

The global Atrial Fibrillation market has an estimated annual growth rate of 6.0% .

Q.3. What are the recent trends of Atrial Fibrillationmarket?

Rise of hybrid ablation procedures and growing focus on artificial intelligence (ai) and machine learningare someof the major trends of the market that is projected to boost the market growth in the near future.

Q.4. Which are the top companies to hold the market share in Atrial Fibrillation?

The major companies profiled in this report include AtriCure Inc., Abbott (St. Jude Medical Inc.), Boehringer Ingelheim GmbH, Boston Scientific Corporation, Bristol- Myers Squibb Corporation, Biosense Webster Inc., Cardio Focus Inc., Endoscopic Technologies Inc., Johnsons & Johnson, Sanofi Aventis, among others.

Q.5. Which region is estimated to held highest CAGR inAtrial Fibrillationmarket?

North America is estimated to hold biggest share in the market for Atrial Fibrillation.

Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!

Start-up
Profiling

One of our marquee services We profile relevant start-up companies in the market.

KOL
Insight's

Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.